Evidence map›Paper›PMID 41933048›Full record

ArticleCell death and differentiation2026

Multiple pathways of CD34

Ting Wang, Hui Gong, Guoguo Ye, Ruihan Chen, Shasha Sun, Xueyin Huang, Bohuan Zhang, Liujun Jiang, Yuesheng Zhang, Tingting Chen and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ting Wang *Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID http://orcid.org/0000-0002-6027-4914
Hui Gong *Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Guoguo Ye *Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ruihan ChenDepartment of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Shasha SunDepartment of Cardiology, Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Xueyin HuangDepartment of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Bohuan ZhangDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liujun JiangDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yuesheng ZhangDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Tingting ChenDepartment of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine and Zhejiang Key Laboratory of Integrative Chinese and Western Medicine for Diagnosis and Treatment of Circulatory Diseases, Hangzhou, China.
Yuqing PanDepartment of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine and Zhejiang Key Laboratory of Integrative Chinese and Western Medicine for Diagnosis and Treatment of Circulatory Diseases, Hangzhou, China.
Jinghong XuDepartment of Pathology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Min JinDepartment of Reproductive Medicine, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Kai ChenDepartment of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. kai_chen@zju.edu.cn.ORCID http://orcid.org/0000-0002-4059-796X
Wei MaoDepartment of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine and Zhejiang Key Laboratory of Integrative Chinese and Western Medicine for Diagnosis and Treatment of Circulatory Diseases, Hangzhou, China. maoweilw@163.com.
Qingbo XuDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. qingbo_xu@zju.edu.cn.ORCID http://orcid.org/0000-0002-6414-2273

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31830039National Natural Science Foundation of China (National Science Foundation of China) 82030008National Natural Science Foundation of China (National Science Foundation of China) 82200479National Natural Science Foundation of China (National Science Foundation of China) 82400490National Natural Science Foundation of China (National Science Foundation of China) 82400575National Natural Science Foundation of China (National Science Foundation of China) U24A20799National Natural Science Foundation of China (National Science Foundation of China) W2541023Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LMS25H020009
6 · The paper itself

Abstract

CD34 has long been defined as a canonical marker for endothelial progenitors as well as hematopoietic stem cells, implicating its role in vascular development and hematopoiesis. However, the precise developmental hierarchy and lineage potential of CD34

Identifiers

PMID41933048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.